Company intelligence / Profile preview

Honz Pharmaceutical

Guangzhou, Guangdong, China

Ownership: Private
Employees: ~751
Development stage: Other

Overview

Honz Pharmaceutical focuses on pediatric and family medicines, with a strong presence in China’s children’s healthcare market. Its portfolio includes both Chinese and Western medicines, with several approved products such as Zhike Juhong Granules for cough and combination therapies like ibuprofen/phenylephrine hydrochloride in late-stage clinical development or approved status. The company has a leading domestic position in child drug R&D and production capacity.

Therapeutic areas: PulmonologyInfectious Diseases
Modalities: Small moleculeHerbal medicine
Industry: Biotech

Partnerships

No major global pharmaceutical partnerships publicly disclosed.

Beyond the preview

Go deeper on Honz Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Honz Pharmaceutical.

Explore the full profile